Use of the Biphasic <sup>13</sup>C-Sucrose/Glucose Breath Test to Assess Sucrose Maldigestion in Adults with Functional Bowel Disorders

<div>Between-group comparisons of biphasic <sup>13</sup>C-sucrose/<sup>13</sup>C-glucose breath test data obtained from symptomatic patients with FBD and asymptomatic adult control subjects. Patients with FBD demonstrated decreased coefficient of glucose oxidation values for <sup>13</sup>C-sucrose at 60-, 75-, and mean 60–75-minute time points when compared with asymptomatic controls.</div>

BioMed Research International

fig3

Figure 3

Figure 3: Use of the Biphasic <sup>13</sup>C-Sucrose/Glucose Breath Test to Assess Sucrose Maldigestion in Adults with Functional Bowel Disorders 

BioMed Research International

Use of the Biphasic 13C-Sucrose/Glucose Breath Test to Assess Sucrose Maldigestion in Adults with Functional Bowel Disorders

Figure 3

Use of the Biphasic ¹³C-Sucrose/Glucose Breath Test to Assess Sucrose Maldigestion in Adults with Functional Bowel Disorders